grant
WASHINGTON UNIVERSITY / SITEMAN CANCER CENTER LEAD ACADEMIC SITE
Organization WASHINGTON UNIVERSITYLocation SAINT LOUIS, UNITED STATESPosted 5 Mar 2019Deadline 29 Feb 2032
NIHUS FederalResearch GrantFY2026ACRINAcute leukemiaAddressAmbulatory Care FacilitiesAmerican College of Radiology Imaging NetworkAreaBreast CancerCancer CenterCancer ControlCancer Control ScienceCancer TreatmentCancersCaringClinicClinical ResearchClinical StudyClinical TrialsCollaborationsCommunicationComprehensive Cancer CenterCooperative Group ProgramCorrelative StudyCountyDataDevelopmentDiagnostic ServicesDiseaseDisorderECOGEastern Cooperative Oncology GroupFacultyFosteringGeneral RadiologyGenomicsGerminoblastic SarcomaGerminoblastomaGoalsGynecologic OncologyHistoryIllinoisImageInstitutionInvestigatorsInvestmentsLeadLeadershipLocationLymphomaMalignant Breast NeoplasmMalignant LymphomaMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant Neoplasm of the UterusMalignant NeoplasmsMalignant Ovarian NeoplasmMalignant Ovarian TumorMalignant Soft Tissue NeoplasmMalignant TumorMalignant Tumor of the LungMalignant Tumor of the OvaryMalignant Tumor of the UterusMalignant Uterine NeoplasmMalignant Uterine TumorMalignant neoplasm of lungMalignant neoplasm of ovaryMedicalMedical OncologyMentorsMentorshipMissionMissouriModalityMolecularOncologyOncology CancerOutpatient ClinicsOvary CancerPathologyPatientsPb elementPharmaceutic ServicesPharmaceutical ServicesPharmacy ServicesPhysiciansPlayPositionPositioning AttributePrincipal InvestigatorPrognostic MarkerProtocolProtocols documentationPulmonary CancerPulmonary malignant NeoplasmQOLQuality of lifeRadiation OncologyRadiologyRadiology SpecialtyRecording of previous eventsRectal CancerRectal CarcinomaReportingResearch PersonnelResearchersResistanceReticulolymphosarcomaSarcomaSiteSpecialistTherapeuticTherapeutic TrialsTranslational ResearchTranslational ScienceUniversitiesUterine CancerUterus CancerWashingtonanti-cancer researchanti-cancer therapybasebasesbiobankbiorepositorycancer researchcancer therapycancer-directed therapycancers that are rarecontrol trialdesigndesigningdevelopmentaldiagnosis servicediagnostic toolexperienceheavy metal Pbheavy metal leadhistoriesimagingimaging programimaging studyimprovedlung cancermalignancymalignant breast tumormalignant soft tissue tumormembermetropolitanmolecular imagingmolecule imagingmultidisciplinaryneoplasm/cancernoveloperationoperationsovarian cancerpredictive biological markerpredictive biomarkerspredictive markerpredictive molecular biomarkerprofessorprognostic biomarkerprognostic indicatorprogramsproteogenomicsrare cancerrare malignancyrare tumorresistantresponsesq. ftsquare footsuccesstranslation researchtranslational investigationtranslational investigatortranslational researchertranslational scientist
Description preview
Project Summary
The fundamental goal of the proposed Washington University/Siteman Cancer Center (WU/SCC) NCTN Lead
Academic Participating Site UG1 is to 1) foster scientific leadership and mentorship in the NCTN, 2) participate
in the development of NCTN therapeutic, correlative, and cancer control trials, and 3) maintain strong accrual
to…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click